The ClinicalTrials.gov registry shows multiple ongoing tirzepatide studies, but all focus on metabolic endpoints (weight loss, diabetes management, cardiovascular outcomes, obstructive sleep apnea) rather than autoimmune disease activity
Compared with the placebo group, skin desquamation, hydration, skin wrinkling, and elasticity were significantly improved after 4, 4, 12, and 12 weeks of administration, respectively
Heres what the sellers don't mention: There are NO large-scale, randomized, placebo-controlled clinical trials for BPC-157 in humans
The efficacy of DEFA1 is higher than that of the antimicrobial peptide magainin II and the conventional antibiotics ampicillin, clarithromycin or rifampicin, typically used for treatment of Rh